Industry / Germany
Dr Reddy's Sales Impacted By AOK Tenders
January 2011 | Industry Trend AnalysisBMI View: Germany is keen to promote the use of generic drugs as it battles soaring drug spending. Therefore, while the sales of innovative drugs may experience a decline in Germany as a result of the patent cliff and the subsequent rise in generic competition, we believe the high consumption of generic medicines by volume (75% in 2009) highlights opportunities for generic drugmakers in Europe's largest drug market.
To read the full article, please choose one of the following options:
Subcribers please log in
